独白 发表于 2025-3-27 00:30:27

Submitted on: 11 June 2001.
Revised on: 20 September 2001.
Accepted on: 11 November 2001.

___________________CLINICAL DRUG INVESTIGATION---ADIS INT LTD

labile 发表于 2025-3-27 03:35:42

Submitted on: 26 August 2008.
Revised on: 20 September 2008.
Accepted on: 16 November 2008.

___________________CLINICAL DRUG INVESTIGATION---ADIS INT LTD

Expurgate 发表于 2025-3-27 08:08:25

Submitted on: 28 December 2000.
Revised on: 08 April 2001.
Accepted on: 04 May 2001.

___________________CLINICAL DRUG INVESTIGATION---ADIS INT LTD

破译密码 发表于 2025-3-27 12:07:02

Submitted on: 28 December 2009.
Revised on: 13 March 2010.
Accepted on: 29 March 2010.

___________________CLINICAL DRUG INVESTIGATION---ADIS INT LTD

串通 发表于 2025-3-27 15:00:36

Submitted on: 14 February 2025.
Revised on: 16 April 2025.
Accepted on: 03 May 2025.

___________________CLINICAL DRUG INVESTIGATION---ADIS INT LTD

micronized 发表于 2025-3-27 20:57:41

Submitted on: 16 August 2001.
Revised on: 08 November 2001.
Accepted on: 02 January 2002.

___________________CLINICAL DRUG INVESTIGATION---ADIS INT LTD
页: 1 2 3 [4]
查看完整版本: SCIE期刊CLINICAL DRUG INVESTIGATION 2024/2025影响因子:2.922 (CLIN DRUG INVEST) (1173-2563). (PHARMACOLOGY & PHARMACY)(药理学与药学)